This leaflet is about the use of oral (by mouth) mesalazine for inflammatory bowel diseases. Mesalazine is also available as enemas or suppositories – these are described in separate leaflets available on the website.
This leaflet has been written specifically about the use of this medicine in children. The information may differ from that provided by the manufacturer. Please read this leaflet carefully. Keep it somewhere safe so that you can read it again.
Mesalazine
Brand names: Asacol® MR, Ipocol®, Mesren MR®, Pentasa®, Salofalk®, Mezavant®
In inflammatory bowel diseases (Crohn’s disease and ulcerative colitis), parts of the colon (large intestine), small intestine and rectum (back passage) become inflamed (red, swollen and sore) and ulcers (sores) may form. This causes symptoms such as diarrhoea, stomach cramps and bleeding from the rectum.
Mesalazine reduces the inflammation in the bowels and so reduces the painful symptoms. It can also prevent future flareups of the disease. It is therefore important that your child continues to take mesalazine once the symptoms have gone.
Mesalazine may be given once, twice or three times a day, depending on which brand your child has. The medicine label will tell you how often to give it to your child.
Your doctor will work out the amount of mesalazine (the dose) that is right for your child. The dose will be shown on the medicine label.
It is important that you follow your doctor’s instructions about how much to give.
Tablets should be swallowed whole with a glass of water, milk or juice. Your child must not chew the tablet. Tablets should not be cut or crushed, as they have a special coating.
Pentasa tablets, however, can be cut in half or into quarters, but should not be crushed. Or, they can be dissolved in a small amount of drink (squash or water) to make a cloudy
mixture. Your child should drink the whole drink as soon as the tablet has dissolved. Do not do this with other brands of tablets.
Granules should be placed on the tongue and swallowed with a glass of water, milk or juice. Your child should not chew the granules.
Mesalazine will start working straight away but it may take a week or so for your child’s symptoms to improve. It will take a few months for the symptoms to go away completely, as it takes time for the intestine to heal.
It is important that your child continues to take the medicine regularly so that the symptoms don’t flare up again.
If you normally give it once or twice each day: If you remember up to 6 hours after you should have given a dose, give your child the missed dose. For example, if you usually give a dose at about 7 am, you can give the missed dose at any time before 1 pm. If you remember after that time, do not give the missed dose. Wait until the next normal dose. You do not need to wake your child up to give a missed dose.
If you normally give it three times a day: Do not give the missed dose. Wait until the next normal dose.
It is unlikely that you will do harm if you give your child an extra dose of mesalazine by mistake. If you are worried that you may have given your child too much mesalazine, contact your doctor or NHS Direct (0845 4647 in England and Wales; 0845 24 24 24 in Scotland).
We use medicines to make our children better, but sometimes they have other effects that we don’t want (side-effects).
Side-effects you must do something about
If your child is short of breath or wheezing, has swelling of the face, lips or tongue, or a rash, they may be allergic to mesalazine. Take them to hospital or call an ambulance straight away.
If your child has any of the following, contact your doctor straight away:
Other side-effects you need to know about
These should all wear off after a few days. If you are worried, or they are still a problem after a week, or get worse, contact your doctor.
Your child’s doctor, pharmacist or nurse will be able to give you more information about mesalazine and about other medicines used to treat inflammatory bowel disease.
30/1/2012
Version 1, January 2012. © NPPG, RCPCH and WellChild 2011, all rights reserved. Reveiwed by: January 2014.
The primary source for the information in this leaflet is the British National Formulary for Children. For details on any other sources used for this leaflet, please contact us
through our website, www.medicinesforchildren.org.uk.
We take great care to make sure that the information in this leaflet is correct and up-to-date. However, medicines can be used in different ways for different patients. It is
important that you ask the advice of your doctor or pharmacist if you are not sure about something. This leaflet is about the use of these medicines in the UK, and may not apply
to other countries. The Royal College of Paediatrics and Child Health (RCPCH), the Neonatal and Paediatric Pharmacists Group (NPPG), WellChild and the contributors and
editors cannot be held responsible for the accuracy of information, omissions of information, or any actions that may be taken as a consequence of reading this leaflet.